AR115424A1 - ANTI-CD33 ANTIBODIES, ANTI-CD33 / ANTI-CD3 BIS SPECIFIC ANTIBODIES AND USES OF THEM - Google Patents

ANTI-CD33 ANTIBODIES, ANTI-CD33 / ANTI-CD3 BIS SPECIFIC ANTIBODIES AND USES OF THEM

Info

Publication number
AR115424A1
AR115424A1 ARP190101403A ARP190101403A AR115424A1 AR 115424 A1 AR115424 A1 AR 115424A1 AR P190101403 A ARP190101403 A AR P190101403A AR P190101403 A ARP190101403 A AR P190101403A AR 115424 A1 AR115424 A1 AR 115424A1
Authority
AR
Argentina
Prior art keywords
antibodies
antigen
methods
bis
binding fragments
Prior art date
Application number
ARP190101403A
Other languages
Spanish (es)
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of AR115424A1 publication Critical patent/AR115424A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen anticuerpos anti-CD33 y fragmentos de unión al antígeno de estos y anticuerpos biespecíficos anti-CD33 / anti-CD3 o fragmentos de unión al antígeno de estos. También se describen ácidos nucleicos que codifican los anticuerpos, composiciones que componen los anticuerpos, métodos para producir anticuerpos y métodos para usar los anticuerpos para tratar o prevenir enfermedades, tales como el cáncer. Reivindicación 1: Un anticuerpo monoclonal aislado o fragmento de unión al antígeno de este que se une específicamente al dominio C2 de CD33.Anti-CD33 antibodies and antigen-binding fragments thereof and anti-CD33 / anti-CD3 bispecific antibodies or antigen-binding fragments thereof are described. Also described are nucleic acids that encode the antibodies, compositions that make up the antibodies, methods for producing antibodies, and methods for using the antibodies to treat or prevent diseases, such as cancer. Claim 1: An isolated monoclonal antibody or antigen-binding fragment thereof that specifically binds to the C2 domain of CD33.

ARP190101403A 2018-05-24 2019-05-24 ANTI-CD33 ANTIBODIES, ANTI-CD33 / ANTI-CD3 BIS SPECIFIC ANTIBODIES AND USES OF THEM AR115424A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862676123P 2018-05-24 2018-05-24

Publications (1)

Publication Number Publication Date
AR115424A1 true AR115424A1 (en) 2021-01-20

Family

ID=74446278

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190101403A AR115424A1 (en) 2018-05-24 2019-05-24 ANTI-CD33 ANTIBODIES, ANTI-CD33 / ANTI-CD3 BIS SPECIFIC ANTIBODIES AND USES OF THEM

Country Status (1)

Country Link
AR (1) AR115424A1 (en)

Similar Documents

Publication Publication Date Title
NI202000088A (en) ANTI-CD33 ANTIBODIES, ANTI-CD33/ANTI CD3 BISPECIFIC ANTIBODIES AND USES OF THESE
CL2019002566A1 (en) Anti-phf-tau antibodies and their uses.
CL2020003285A1 (en) Bispecific anti-psma x anti-cd28 antibodies and their uses.
CL2020000452A1 (en) B7-h4 antibodies and methods of using them.
CL2018002490A1 (en) Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies that specifically bind to cd3 and / or cd123. (divisional application 201701866)
CL2019002717A1 (en) Enhanced antigen-binding receptors.
ECSP17005649A (en) HUMANIZED ANTI-TAU ANTIBODIES
AR106570A1 (en) ANTI-PSMA ANTIBODIES, BIO-SPECIFIC ANTIGEN MOLECULES THAT JOIN PSMA AND CD3, AND USES OF THESE
PE20170680A1 (en) JOINT TREATMENTS WITH ANTI CD40 ANTIBODIES
AR100680A1 (en) ANTI-DR5 ANTIBODIES AND MOLECULES THAT INCLUDE DR5 JOINT DOMAINS OF THE SAME
ECSP19035482A (en) ANTI-PD-1 / ANTI-HER2 NATURAL ANTI-PD-1 / ANTI-HER2 BIESPECFIC ANTIBODY STRUCTURAL NATURAL ANTIBODY AND METHOD FOR PREPARING THE SAME
DOP2021000229A (en) MATERIALS AND METHODS FOR MODULATING T-SCHEDULE-MEDIATED IMMUNITY
CO2019011458A2 (en) Monoclonal antibody to pd-l1
CO2021007053A2 (en) Methods of Treating Graves' Ophthalmopathy Using Anti-fcrn Antibodies
EA202092125A1 (en) ANTIBODIES AGAINST FOLATE 1 RECEPTOR AND THEIR APPLICATION
EA202190807A1 (en) ANTIBODIES TO SYNUCLEINE
CO2021014153A2 (en) Monoclonal antibody that specifically binds to gitr
ECSP22078815A (en) ANTI-PHF-TAU ANTIBODIES AND THEIR USES
EA202092122A1 (en) ANTIBODIES AGAINST TIP-1 AND THEIR APPLICATION
AR115424A1 (en) ANTI-CD33 ANTIBODIES, ANTI-CD33 / ANTI-CD3 BIS SPECIFIC ANTIBODIES AND USES OF THEM
CL2021001104A1 (en) Monoclonal antibody that specifically binds to the cd20 antigen
EA202092840A1 (en) ANTIBODIES TO CD33, BISPECIFIC ANTIBODIES TO CD33 / CD3 AND THEIR APPLICATION
AR099350A1 (en) SPECIFIC ANTIBODIES FOR BINDING 1A FACTOR TYPE OF TUMOR NECROSIS AND COMPOSITIONS AND USES OF THEM
EA202193035A1 (en) MATERIALS AND METHODS FOR T-CELL-MEDIATED IMMUNE MODULATION
EA202092121A1 (en) ANTIBODIES AGAINST CD73 AND THEIR USE